
I was just scammed for $500K by Polymarket. I am "willo2", the top holder of YES on "MicroStrategy sells Bitcoin by May 31st". Here's what happened:
Listening Post
14 posts


I was just scammed for $500K by Polymarket. I am "willo2", the top holder of YES on "MicroStrategy sells Bitcoin by May 31st". Here's what happened:

New: We are Short T1 Energy (TE) Investors confused T1 as an AI play. It's Not. It is another China Hustle We'll reveal the dirty little secrets of its key IP transfer that hide T1's deep ties to China T1 is FEOCk’ed. Expect major accounting restatements coming soon




Eli Lilly released retatrutide Phase 3 data yesterday. 28% weight loss in 80 weeks. The most powerful obesity drug that’s ever been tested. And today the cancer signal drops. 12,112 patients. Seven tumor types. GLP-1 users had half the lung cancer metastasis rate (10% vs 22%). Breast cancer: 43% cut. Colon cancer five-year mortality in a separate study: 15.5% vs 37.1%. Cancer joins a list that already includes heart disease (SELECT, 20% MACE reduction), kidney failure (FLOW, 24% slower decline), sleep apnea (SURMOUNT-OSA, FDA-approved), addiction (BMJ, 600K veterans, 18-25% reduction across substances), and liver disease (86% fat clearance). Tumors express GLP-1 receptors. Activate them and NF-kB drops, apoptosis rises. The drug isn’t just shrinking fat. It’s talking directly to the cancer. One drug class. Designed for blood sugar. The biology keeps finding uses the designers didn’t predict.


Please do a quick read of this. It’s short, well written, and will remove a bit of wool from over your eyes.


Clemson is $1.5B in debt. Syracuse is closing or pausing 93 programs, UNC-Chapel Hill plans to cut spending by $89M over 3 years. Duke recently let 600 employees go in a $350M budget cut. Indiana public colleges announced a plan to eliminate or merge 580 programs statewide.



Datadog. Czechoslovak Group. Himax. We’ve published a dozen articles over the past 3 months—from a petrochemical giant in Texas to a hidden photonics supplier in Taiwan. Our mission: pioneering a new model to fund investigative journalism.

We just published a short report on $CUE $368.5M in accumulated losses, ZERO products ever sold and a CEO compensation package that costs more than the company's entire forward contracted revenue. The Q4 2025 revenue spike was one licensing payment, that is already gone. A sharp correction is not a prediction but a structural inevitability. Click for our full report ⬇️ fugaziresearch.com/p/cue-reverse-…